Related references
Note: Only part of the references are listed.Histopathology of diffusion-weighted imaging-positive lesions in cerebral amyloid angiopathy
Annemieke ter Telgte et al.
ACTA NEUROPATHOLOGICA (2020)
New Treatment Approaches to Modify the Course of Cerebral Small Vessel Diseases
Eric E. Smith et al.
STROKE (2020)
Cortical Microinfarcts Detected by 3-Tesla Magnetic Resonance Imaging Differentiation Between Cerebral Amyloid Angiopathy and Embolism
Hidehiro Ishikawa et al.
STROKE (2020)
Vital Functions Contribute to the Spread of Extracellular Fluids in the Brain: Comparison Between Life and Death
Alina Piotrowska et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease
Masashi Tanaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy
Bernadett Fakan et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease
Hector Rosas-Hernandez et al.
NEUROSCIENCE (2020)
Demonstrating a reduced capacity for removal of fluid from cerebral white matter and hypoxia in areas of white matter hyperintensity associated with age and dementia
Matthew MacGregor Sharp et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Proportion of intracerebral haemorrhage due to cerebral amyloid angiopathy in the East and West: Comparison between single hospital centres in Japan and the United Kingdom
Yusuke Yakushiji et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Strictly Lobar Microbleeds Reflect Amyloid Angiopathy Regardless of Cerebral and Cerebellar Compartments
Young Hee Jung et al.
STROKE (2020)
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA): Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease-Opportunities for Therapy
Roxana O. Carare et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Cerebral Amyloid Angiopathy Presenting as Massive Subarachnoid Haemorrhage: A Case Study and Review of Literature
Satoshi Saito et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model
Shin Heun Kim et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Alzheimer's disease drug development pipeline: 2020
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Immunotherapy with ponezumab for probable cerebral amyloid angiopathy
Claire Leurent et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Finger-Like Projections in Lobar Haemorrhage on Early Magnetic Resonance Imaging Is Associated with Probable Cerebral Amyloid Angiopathy
Dimitri Renard et al.
CEREBROVASCULAR DISEASES (2019)
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
Masashi Tanaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy
Takayuki Inoue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Development of a Multicomponent Intervention to Prevent Alzheimer's Disease
Satoshi Saito et al.
FRONTIERS IN NEUROLOGY (2019)
Nationwide survey on cerebral amyloid angiopathy in Japan
K. Sakai et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Risk of Intracerebral Hemorrhage and Mortality After Convexity Subarachnoid Hemorrhage in Cerebral Amyloid Angiopathy
Lionel Calviere et al.
STROKE (2019)
Predictors for Late Post-Intracerebral Hemorrhage Dementia in Patients with Probable Cerebral Amyloid Angiopathy
Li Xiong et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
An insight into the health-promoting effects of taxifolin (dihydroquercetin)
Christudas Sunil et al.
PHYTOCHEMISTRY (2019)
BLOOD-BRAIN BARRIER: FROM PHYSIOLOGY TO DISEASE AND BACK
Melanie D. Sweeney et al.
PHYSIOLOGICAL REVIEWS (2019)
Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk
Marco Pasi et al.
NEUROLOGY (2018)
Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy
Gargi Banerjee et al.
STROKE (2018)
The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study
Mark A. Rodrigues et al.
LANCET NEUROLOGY (2018)
Taxifolin prevents β-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A2/prostaglandin E2 content
Yuanyuan Wang et al.
METABOLIC BRAIN DISEASE (2018)
Diagnosis of Cerebral Amyloid Angiopathy Evolution of the Boston Criteria
Steven M. Greenberg et al.
STROKE (2018)
The role of brain vasculature in neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE NEUROSCIENCE (2018)
Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study
Anna M. van Opstal et al.
LANCET NEUROLOGY (2017)
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
Satoshi Saito et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Vascular basement membranes as pathways for the passage of fluid into and out of the brain
Alan W. J. Morris et al.
ACTA NEUROPATHOLOGICA (2016)
Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy
Abby Keable et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Interaction between cerebrovascular disease and Alzheimer pathology
Satoshi Saito et al.
CURRENT OPINION IN PSYCHIATRY (2016)
Detection of 191 Taxifolin Metabolites and Their Distribution in Rats Using HPLC-ESI-IT-TOF-MSn
Ping Yang et al.
MOLECULES (2016)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons
Patricia A. Boyle et al.
NEUROLOGY (2015)
Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload
Haipeng Guo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Cerebral Amyloid Angiopathy: Emerging Concepts
Masahito Yamada
JOURNAL OF STROKE (2015)
Increased Number of Microinfarcts in Alzheimer Disease at 7-T MR Imaging
Sanneke van Rooden et al.
RADIOLOGY (2014)
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy
Satoshi Saito et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders
Yasser Iturria-Medina et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models
Michal Arbel-Ornath et al.
ACTA NEUROPATHOLOGICA (2013)
Structure-Activity Relationship for (+)-Taxifolin Isolated from Silymarin as an Inhibitor of Amyloid β Aggregation
Mizuho Sato et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2013)
Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues
Mizuho Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Estimating cerebral microinfarct burden from autopsy samples
M. Brandon Westover et al.
NEUROLOGY (2013)
Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts
Yoko Okamoto et al.
ACTA NEUROPATHOLOGICA (2012)
Dihydroquercetin: More than just an impurity?
Anita Elaine Weidmann
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
Karen Barnett et al.
LANCET (2012)
Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
Paul S. Aisen et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
Inhibition of Advanced Glycation End Product Formation by Medicinal Plant Extracts Correlates with Phenolic Metabolites and Antioxidant Activity
Cory S. Harris et al.
PLANTA MEDICA (2011)
Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements
Karl Broich et al.
PROGRESS IN NEUROBIOLOGY (2011)
Atraumatic convexal subarachnoid hemorrhage Clinical presentation, imaging patterns, and etiologies
S. Kumar et al.
NEUROLOGY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Cerebrospinal Fluid Amyloid β40 Is Decreased in Cerebral Amyloid Angiopathy
Marcel M. Verbeek et al.
ANNALS OF NEUROLOGY (2009)
Effect of tramiprosate in patients with mild-to-moderate alzheimer's disease: Exploratory analyses of the MRI sub-group of the alphase study
S. Gauthier et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia
Yoko Okamoto et al.
NEUROREPORT (2009)
Cerebral amyloid angiopathy and its relationship to Alzheimer's disease
Dietmar Rudolf Thal et al.
ACTA NEUROPATHOLOGICA (2008)
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology
R. O. Carare et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Francine Gervais et al.
NEUROBIOLOGY OF AGING (2007)
A phase 2 study of tramiprosate for cerebral amyloid angiopathy
Steven M. Greenberg et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients -: A biochemical analysis
R. Lyle Patton et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)